# lansoprazole

NDC: 45802-878
Generic name: Lansoprazole
Labeler / Manufacturer: Padagis Israel Pharmaceuticals Ltd
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, DELAYED RELEASE
Routes: ORAL
Marketing started: 20210729

FDA application: ANDA202319

## Active ingredients

- LANSOPRAZOLE: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"45802-878"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=45802-878
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17f41872-f3d1-4b02-b6ce-0e731139495a